Macquarie Group’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,883
Closed -$10 2058
2024
Q1
$10 Buy
+5,883
New +$4.93K ﹤0.01% 1727
2022
Q4
Sell
-6,866
Closed -$17K 2001
2022
Q3
$17K Sell
6,866
-2,776
-29% -$6.91K ﹤0.01% 2258
2022
Q2
$22K Hold
9,642
﹤0.01% 2278
2022
Q1
$32 Hold
9,642
﹤0.01% 2279
2021
Q4
$44K Buy
9,642
+2,776
+40% +$21K ﹤0.01% 2199
2021
Q3
$49K Hold
6,866
﹤0.01% 2243
2021
Q2
$55K Buy
+6,866
New +$57.9K ﹤0.01% 2142
2018
Q1
Sell
-78
Closed -$10K 2309
2017
Q4
$10K Buy
+78
New +$9.54K ﹤0.01% 2260

Other funds holding OCGN

Macquarie Group's OCGN Position: Q2 2024 in Review

Macquarie Group sold out of Ocugen (OCGN) in Q2 2024, closing a stake of 5,883 shares — an estimated $10 sold.

Macquarie Group first reported a position in OCGN in Q4 2017 and held it in 8 quarters. The position peaked at $55K in Q2 2021. 101 funds tracked by Wall St. Rank hold OCGN as of Q2 2024.

  • Macquarie Group reported no remaining Ocugen position as of Q2 2024 after selling out during the quarter.
  • Macquarie Group sold 5,883 Ocugen shares in Q2 2024, an estimated $10.
  • Macquarie Group first reported a position in Ocugen in Q4 2017 and held it in 8 quarters.
  • Macquarie Group's Ocugen position peaked at $55K in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Ocugen as of Q2 2024.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.